Effectiveness and tolerability of transdermal rivastigmine in the treatment of Alzheimer&rsquo;s disease in daily practice

Código QR

Effectiveness and tolerability of transdermal rivastigmine in the treatment of Alzheimer&rsquo;s disease in daily practice

Johannes Seibert1, Ferenc Tracik2,3, Konstantin Articus2, Stefan Spittler41Outpatient Clinic, Heidelberg, Germany; 2Novartis Pharma, N&uuml;rnberg, Germany; 3Department of Neurology, Heinrich-Heine University, D&uuml;sseldorf, Germany; 4Alexianer Krefeld, Maria Hilf Clinic, Krefeld,...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Seibert J, Tracik F, Articus K, Spittler S
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2012
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/1c1a13b280bf4e608824e44d3ae4c4f9
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Rivastigmine for the treatment of dementia associated with Parkinson&rsquo;s disease
por: Jennifer L Reingold, et al.
Publicado: (2007)

Two cases of Alzheimer&#39;s disease showing deterioration of behavioral and psychological symptoms of dementia induced by switching from rivastigmine to donepezil
por: Kimura T, et al.
Publicado: (2012)

An update on the toxicity of A&beta; in Alzheimer&rsquo;s disease
por: J&uuml;rgen G&ouml;tz, et al.
Publicado: (2008)

Domperidone effective in preventing rivastigmine-related gastrointestinal disturbances in patients with Alzheimer's disease
por: Kano O, et al.
Publicado: (2013)

Update on the use of memantine in Alzheimer&rsquo;s disease
por: Robert J van Marum
Publicado: (2009)

Ceruloplasmin and iron in Alzheimer&rsquo;s disease and Parkinson&rsquo;s disease: a synopsis of recent studies
por: Kristinsson J, et al.
Publicado: (2012)

Brain amyloid &beta; protein and memory disruption in Alzheimer&rsquo;s disease
por: Weiming Xia
Publicado: (2010)

Errorless learning and spaced retrieval techniques to relearn instrumental activities of daily living in mild Alzheimer&rsquo;s disease: A case report study
por: St&eacute;phanie Thivierge, et al.
Publicado: (2008)

Intrathecal corticosteroids might slow Alzheimer&rsquo;s disease progression
por: Joseph Martin Alisky
Publicado: (2008)

Present and prospective clinical therapeutic regimens for Alzheimer&rsquo;s disease
por: Mustafa M Husain, et al.
Publicado: (2008)

Rivastigmine in Chinese patients with subcortical vascular dementia
por: Vincent Mok, et al.
Publicado: (2007)

Once-daily pramipexole for the treatment of early and advanced idiopathic Parkinson&rsquo;s disease: implications for patients
por: Antonini A, et al.
Publicado: (2011)

Optimal management of Alzheimer&rsquo;s disease patients: Clinical guidelines and family advice
por: Julia Haberstroh, et al.
Publicado: (2010)

Could lysine supplementation prevent Alzheimer&rsquo;s dementia? A novel hypothesis
por: Robert N Rubey
Publicado: (2010)

Brain ischemia and ischemic blood&ndash;brain barrier as etiological factors in sporadic Alzheimer&rsquo;s disease
por: Ryszard Pluta, et al.
Publicado: (2008)

Reproductive life events and Alzheimer&rsquo;s disease in Italian women: a retrospective study
por: Bono G, et al.
Publicado: (2012)

Prolonged cholinergic enrichment influences regional cortical activation in early Alzheimer&rsquo;s disease
por: William J McGeown, et al.
Publicado: (2008)

Critical appraisal of the long-term impact of memantine in treatment of moderate to severe Alzheimer&rsquo;s disease
por: Umamon Puangthong, et al.
Publicado: (2009)

Estrogen receptor-mediated neuroprotection: The role of the Alzheimer&rsquo;s disease-related gene seladin-1
por: Alessandro Peri, et al.
Publicado: (2008)

Neuroinflammation in Alzheimer’s disease
por: Zhang FJ, et al.
Publicado: (2015)

Diffusion tensor imaging investigations in Alzheimer&rsquo;s disease: the resurgence of white matter compromise in&nbsp;the cortical dysfunction of the aging brain
por: David A Medina, et al.
Publicado: (2008)

A review of the potential therapeutic role of statins in the treatment of Alzheimer&rsquo;s disease: current research and opinion
por: Mitchell AJ, et al.
Publicado: (2013)

Functional imaging of hippocampal dysfunction among persons with Alzheimer&rsquo;s disease: a proof-of-concept study
por: David B Arciniegas, et al.
Publicado: (2010)

Neuroanatomical abnormalities before onset of delusions in patients with Alzheimer&rsquo;s disease: a voxel-based morphometry study
por: Nakaaki S, et al.
Publicado: (2012)

The efficacy of mirtazapine in agitated patients with Alzheimer&rsquo;s disease: A 12-week open-label pilot study
por: Sibel Cakir, et al.
Publicado: (2008)

The effects of rivastigmine plus selegiline on brain acetylcholinesterase, (Na+,&nbsp;K+)-, Mg2+-ATPase activities, antioxidant status, and learning performance of aged rats
por: Haris Carageorgiou, et al.
Publicado: (2008)

Neurosteroids block the increase in intracellular calcium level induced by Alzheimer&rsquo;s &beta;-amyloid protein in long-term cultured rat hippocampal neurons
por: Midori Kato-Negishi, et al.
Publicado: (2008)

Galantamine versus donepezil in Chinese patients with Alzheimer&rsquo;s disease: results from a randomized, double-blind study
por: Zhang Z, et al.
Publicado: (2012)

Clinically meaningful treatment responses after switching to galantamine and with addition of memantine in patients with Alzheimer&rsquo;s disease receiving donepezil
por: Kano O, et al.
Publicado: (2013)

Editor&rsquo;s choice: the best of 2011&ndash;2012
por: Pinder RM
Publicado: (2013)

Magnetic resonance spectroscopy in Alzheimer’s disease
por: Graff-Radford J, et al.
Publicado: (2013)

Rasagiline in treatment of Parkinson&rsquo;s disease
por: Lakshmi Nayak, et al.
Publicado: (2008)

Sleep disorders in Parkinson&rsquo;s disease
por: Israt Jahan, et al.
Publicado: (2009)

The impact of nocturnal disturbances on daily quality of life in patients with Parkinson’s disease
por: Yu RL, et al.
Publicado: (2015)

Current approaches to the treatment of Parkinson&rsquo;s disease
por: Joseph Jankovic, et al.
Publicado: (2008)

Update on ropinirole in the treatment of Parkinson&rsquo;s disease
por: Holly A Shill, et al.
Publicado: (2008)

Parkinson&rsquo;s disease patients&rsquo; subjective descriptions of characteristics of chronic pain, sleeping patterns and health-related quality of life
por: Skogar &Ouml;, et al.
Publicado: (2012)

Activation of mTOR: a culprit of Alzheimer’s disease?
por: Cai Z, et al.
Publicado: (2015)

Optimal treatment of Alzheimer’s disease psychosis: challenges and solutions
por: Koppel J, et al.
Publicado: (2014)

Neuro-Beh&ccedil;et&rsquo;s disease: A report of sixteen patients
por: Radi Shahien, et al.
Publicado: (2010)